News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
URDAL DAVID
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/07/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/14/2012 |
4
| URDAL DAVID (Director) has filed a Form 4 on DENDREON CORP|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 10/25/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 1,016 shares
@ $10.1, valued at
$10.3k
|
|
| 10/19/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 5,313 shares
@ $9.65, valued at
$51.3k
Sold 2,036 shares
@ $9.65, valued at
$19.6k
|
|
| 08/10/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Exercised 3,281 options to buy
@ $4.41, valued at
$14.5k
Exercised 8,754 options to buy
@ $4.9, valued at
$42.9k
|
|
| 07/19/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 5,312 shares
@ $39.19, valued at
$208.2k
Sold 2,035 shares
@ $38.43, valued at
$78.2k
|
|
| 04/25/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 1,016 shares
@ $41.04, valued at
$41.7k
|
|
| 04/19/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 5,313 shares
@ $42.1208, valued at
$223.8k
Sold 8,898 shares
@ $41.58, valued at
$370k
Sold 2,035 shares
@ $41.68, valued at
$84.8k
|
|
| 03/31/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 85,716 shares
@ $35, valued at
$3M
|
|
| 01/24/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Granted 14,026 shares
@ $0
Paid exercise price by delivering 1,075 shares
@ $35.05, valued at
$37.7k
|
|
| 01/20/2011 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Paid exercise price by delivering 186 shares
@ $36.9, valued at
$6.9k
Paid exercise price by delivering 186 shares
@ $36.9, valued at
$6.9k
|
|
| 01/19/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/09/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 7,369 shares
@ $40.6558, valued at
$299.6k
Sold 5,000 shares
@ $40.41, valued at
$202.1k
Sold 5,000 shares
@ $40.37, valued at
$201.9k
Sold 5,000 shares
@ $42, valued at
$210k
Sold 10,000 shares
@ $42.55, valued at
$425.5k
|
|
| 09/03/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 5,000 shares
@ $40, valued at
$200k
Sold 5,000 shares
@ $41, valued at
$205k
|
|
| 09/01/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/27/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 7,369 shares
@ $35.9317, valued at
$264.8k
|
|
| 08/05/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 40,000 shares
@ $39.2075, valued at
$1.6M
|
|
| 05/25/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Exercised 19,219 options to buy
@ $4.41, valued at
$84.8k
Exercised 16,924 options to buy
@ $4.9, valued at
$82.9k
Exercised 20,856 options to buy
@ $4.95, valued at
$103.2k
Exercised 30,000 options to buy
@ $5.45, valued at
$163.5k
Exercised 14,080 options to buy
@ $5.74, valued at
$80.8k
Exercised 4,382 options to buy
@ $9.77, valued at
$42.8k
Exercised 12,588 options to buy
@ $14.0625, valued at
$177k
|
|
| 05/04/2010 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Sold 32,268 shares
@ $53.9337, valued at
$1.7M
Sold 7,732 shares
@ $53.9337, valued at
$417k
|
|
| 01/25/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/10/2009 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP|
Txns:
| Granted 11,505 options to buy
@ $26.64, valued at
$306.5k
Granted 20,995 options to buy
@ $26.64, valued at
$559.3k
|
|
| 10/22/2009 |
4
| URDAL DAVID (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC. |
| 05/05/2009 |
4
| URDAL DAVID (SVP, Chief Scientific Officer) has filed a Form 4 on DENDREON CORP |
| 01/20/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
|
|